Tirzepatide is a weekly injection used for type 2 diabetes and for weight management, sold under brand names including Mounjaro. It acts on two gut hormone pathways rather than one, which is the main difference from semaglutide, though the side-effect profile is broadly similar.

As with the wider class, most effects are digestive and follow dose increases, and the serious ones are uncommon but recognisable.

Common side effects during long-term use

Digestive effects usually ease over several weeks at a steady dose, and because they follow the dose they often return briefly at each escalation step before settling again. Smaller meals, eating more slowly and stopping when full generally help.

Tirzepatide alone is not a common cause of low blood sugar, but that risk rises alongside insulin or a sulfonylurea, and those doses may need adjusting.

Serious or persistent symptoms to discuss with a clinician

Pancreatitis. Severe, persistent abdominal pain, often in the upper abdomen and sometimes spreading through to the back, usually with vomiting and not relieved by the usual measures. This needs urgent assessment.

Gallbladder problems. Pain in the upper right abdomen, fever, yellowing of the eyes or skin, or pale stools. Gallstones are recognised with this class, particularly alongside rapid weight loss.

Dehydration and kidney strain. Prolonged vomiting or diarrhoea can reduce fluid enough to affect the kidneys. Passing much less urine, marked dizziness on standing, or being unable to keep fluids down all warrant same-day contact.

Vision changes. Report new or worsening vision problems, particularly with diabetic eye disease, since rapid improvements in blood sugar can temporarily affect the retina.

Allergic reaction. Swelling of the face or throat, difficulty breathing, or a widespread rash needs emergency care.

This medicine class is not suitable for people with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2. Tell your prescriber if either applies, and report a new neck lump, hoarseness or difficulty swallowing.

Dose changes, missed doses and monitoring tests

The dose is increased in steps at set intervals to allow tolerance to build. Moving up faster than advised is the usual reason people experience severe nausea, and holding at a step for longer is a reasonable request.

It is a weekly injection, so missed-dose rules are specific and set out in the leaflet. Never double up to catch up.

Monitoring usually includes blood glucose and HbA1c, kidney function, weight, and eye checks where relevant.

Rapid weight loss has consequences worth planning for, including muscle loss and gallstones. Adequate protein intake and resistance exercise are commonly advised alongside, and are worth asking about rather than discovering later.

Interactions with OTC medicines and supplements

Buying these medicines outside a pharmacy carries real risk. Falsified pens have been reported internationally, and demand has driven a market in products of unknown origin, including compounded and unlicensed preparations. A pen bought through social media or an informal seller may contain the wrong substance, the wrong amount, or nothing useful at all. See fake medicines in South Africa and falsified medicines.

What to ask your doctor before changing treatment

Related chronic medication guides

See also Mounjaro and semaglutide.

Medical Disclaimer: This content is for informational and educational purposes only and does not constitute medical diagnosis, prescription, or professional advice. Always read the patient information leaflet and consult a qualified doctor or pharmacist regarding any medicine or health concern.